Published in Gene Therapy Weekly, March 4th, 1996
Replication defective adenovirus vectors have become the vector of choice for a majority of researchers studying vascular disease and its potential therapies. Adenoviruses have an efficient rate of arterial gene transfer in nondividing cells, they are easy to prepare and produce a high-titer virus concentration.
Potential disadvantages of adenovirus as an arterial gene transfer vector include the induction of both humoral and cellular immune responses by the virus. Researchers have attempted to bypass this problem by rendering the virus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.